Abstract
The aim of this study was to investigate the efficacy of 2-hydroxypropyl-beta-cyclodextrin (HPBCD) as an antidotal treatment for the in vivo cardiovascular effects of amitriptyline poisoning. Experiments were carried out on 33 Wistar rats. To evaluate cardiovascular effects of HPBCD, rats were infused with dextrose or HPBCD. In the poisoning model, amitriptyline (0.94 mg/kg/min) was infused until the mean arterial blood pressure (MAP) dropped to 50 % of the baseline. Following amitriptyline infusion, dextrose, low-dose HPBCD (4.19 mg/kg/min), or high-dose HPBCD (16.76 mg/kg/min) was infused, and MAP, heart rate (HR), and electrocardiogram were recorded for 60 min. Hearts were examined for tissue damage and apoptosis. HPBCD infusion alone did not yield significant difference for MAP, HR, QRS duration, QT interval, and cardiac tissue damage when compared to dextrose (p > 0.05). In the poisoning model, MAP and HR decreased, while QRS duration and QT interval prolonged significantly following amitriptyline infusion (p < 0.0167). Dextrose, low-dose HPBCD, and high-dose HPBCD infusion similarly corrected MAP, HR, QRS duration, and QT interval values at the end-experiment time point (p > 0.05). Histological scores for tissue damage and apoptosis showed no significant difference between the groups (p > 0.05). Based on our results, HPBCD did not show cardiovascular toxicity, while it was not more effective than dextrose for the treatment of amitriptyline poisoning. Further antidotal studies of cyclodextrins with higher doses and/or binding affinities are needed for poisonings.
Similar content being viewed by others
References
Unverir, P., Atilla, R., Karcioglu, O., Topacoglu, H., Demiral, Y., & Tuncok, Y. (2006). A retrospective analysis of antidepressant poisonings in the emergency department: 11-Year experience. Human and Experimental Toxicology, 25, 605–612.
Mowry, J. B., Spyker, D. A., Cantilena, L. R, Jr, McMillan, N., & Ford, M. (2014). 2013 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual report. Clinical Toxicology (Philadelphia), 52, 1032–1283.
Kerr, G. W., McGuffie, A. C., & Wilkie, S. (2001). Tricyclic antidepressant overdose: A review. Emergency Medicine Journal, 18, 236–241.
Thanacoody, H. K., & Thomas, S. H. (2005). Tricyclic antidepressant poisoning: Cardiovascular toxicity. Toxicological Reviews, 24, 205–214.
Bateman, D. N. (2005). Tricyclic antidepressant poisoning: Central nervous system effects and management. Toxicological Reviews, 24, 181–186.
Bradberry, S. M., Thanacoody, H. K., Watt, B. E., Thomas, S. H., & Vale, J. A. (2005). Management of the cardiovascular complications of tricyclic antidepressant poisoning: Role of sodium bicarbonate. Toxicological Reviews, 24, 195–204.
Heard, K., Dart, R. C., Bogdan, G., O’Malley, G. F., Burkhart, K. K., Donovan, J. W., & Ward, S. B. (2006). A preliminary study of tricyclic antidepressant (TCA) ovine FAB for TCA toxicity. Clinical Toxicology (Philadelphia), 44, 275–281.
Litonius, E., Niiya, T., Neuvonen, P. J., & Rosenberg, P. H. (2012). No antidotal effect of intravenous lipid emulsion in experimental amitriptyline intoxication despite significant entrapment of amitriptyline. Basic & Clinical Pharmacology & Toxicology, 110, 378–383.
Heinonen, J. A., Litonius, E., Backman, J. T., Neuvonen, P. J., & Rosenberg, P. H. (2013). Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration—An experimental intoxication study in pigs. Basic & Clinical Pharmacology & Toxicology, 113, 193–200.
Welliver, M., McDonough, J., Kalynych, N., & Redfern, R. (2009). Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent. Journal of Drug Design, Development and Therapy, 2, 49–59.
Abrishami, A., Ho, J., Wong, J., Yin, L., & Chung, F. (2009). Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database of Systematic Reviews, Oct 7, CD007362.
Georgiou, M. E., Georgiou, C. A., & Koupparis, M. A. (1999). Rapid automated spectrophotometric competitive complexation studies of drugs with cyclodextrins using the flow injection gradient technique: Tricyclic antidepressant drugs with alpha-cyclodextrin. Analyst, 124, 391–396.
Junquera, E., Romero, J. C., & Aicart, E. (2001). Behavior of tricyclic antidepressants in aqueous solution: Self-aggregation and association with beta-cyclodextrin. Langmuir, 17, 1826–1832.
Cano, J., Rodriguez, A., Aicart, E., & Junquera, E. (2007). Temperature effect on the complex formation between tricyclic antidepressant drugs (amitriptyline or imipramine) and hydroxypropyl-beta-cyclodextrin in water. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 59, 279–285.
Stella, V. J., & He, Q. (2008). Cyclodextrins. Toxicologic Pathology, 36, 30–42.
Gould, S., & Scott, R. C. (2005). 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): A toxicology review. Food and Chemical Toxicology, 43, 1451–1459.
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010). Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biology, 8, e1000412.
Kalkan, S., Aygoren, O., Akgun, A., Gidener, S., Guven, H., & Tuncok, Y. (2004). Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats? Journal of Toxicology - Clinical Toxicology, 42, 945–954.
Cecen, E., Dost, T., Culhaci, N., Karul, A., Ergur, B., & Birincioglu, M. (2011). Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pacific Journal of Cancer Prevention, 12, 2697–2704.
Tuzun, F., Gencpinar, P., Ozbal, S., Dilek, M., Ergur, B. U., Duman, N., et al. (2012). Neuroprotective effect of neotrofin in a neonatal rat model of periventricular leukomalacia. Neuroscience Letters, 520, 6–10.
Brewster, M. E., Estes, K. S., & Bodor, N. (1990). An intravenous toxicity study of 2-hydroxypropyl-beta-cyclodextrin, a useful drug solubilizer, in rats and monkeys. International Journal of Pharmaceutics, 59, 231–243.
May, C., & Stewart, P. L. (1998). Development of a toxin-binding agent as a treatment for tunicaminyluracil toxicity: protection against tunicamycin poisoning of sheep. Australian Veterinary Journal, 76, 752–756.
Verster, R. S., & Botha, C. J. (2004). Evaluation of hydroxypropyl-beta-cyclodextrin in the treatment of aldicarb poisoning in rats. Journal of the South African Veterinary Association, 75, 182–185.
Mottram, A. R., Bryant, S. M., & Aks, S. E. (2011). Effect of cyclodextrin infusion in a rat model of verapamil toxicity. American Journal of Therapeutics, 18, 371–374.
Ozbilgin, S., Ozbilgin, M., Kucukoztas, B., Kamaci, G., Unek, T., Yurtlu, B. S., et al. (2013). Evaluation of the effectiveness of sugammadex for verapamil intoxication. Basic & Clinical Pharmacology & Toxicology, 113, 280–285.
de Boer, H. D., van Egmond, J., van de Pol, F., Bom, A., & Booij, L. H. D. J. (2006). Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys. Anesthesiology, 104, 718–723.
Epemolu, O., Bom, A., Hope, F., & Mason, R. (2003). Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology, 99, 632–637.
Zwiers, A., van den Heuvel, M., Smeets, J., & Rutherford, S. (2011). Assessment of the potential for displacement interactions with sugammadex: A pharmacokinetic-pharmacodynamic modelling approach. Clinical Drug Investigation, 31, 101–111.
Acknowledgments
The results of this study were presented as a poster at the 23rd National Pharmacology Congress of Turkish Pharmacological Society.
Funding
This study was funded by Dokuz Eylul University Scientific Research Projects Coordination Unit (Grant No.: 2013.KB.SAG.022). The funder played no role in the design, conduct, or dissemination of the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
B Aydin has received personal fees and travel and meeting grants from EU FP7 Project ‘European Clinical Research Infrastructure Network—Integrating Activity.’ The other authors declare no competing interest.
Rights and permissions
About this article
Cite this article
Aydin, B., Hocaoglu, N., Micili, S.C. et al. Effects of 2-Hydroxypropyl-Beta-Cyclodextrin on Cardiovascular Signs of Amitriptyline Poisoning in a Rat Model. Cardiovasc Toxicol 16, 374–380 (2016). https://doi.org/10.1007/s12012-015-9349-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-015-9349-4